MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.parkreldis.2022.02.020

Медицинская библиотека · Parkinsonism & related disorders · 2022

Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.

Jeong Seong Ho, Lee Hye Sun, Jung Jin Ho, Baik Kyoungwon, Sohn Young H, Chung Seok Jong, Lee Phil Hyu

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

This study investigated the relationship between white matter hyperintensities (WMHs), nigrostriatal dopamine deficits, and cognitive decline in patients with drug-naïve early-stage Parkinson's disease (PD).

METHOD: This cross-sectional study enrolled 309 non-demented patients with de novo PD who underwent [18F] N-(3-fluoropropyl)-2β-carbonethoxy-3β-(4-iodophenyl) nortropane positron emission tomography, brain magnetic resonance imaging, and a detailed neuropsychological test at baseline. We quantified dopamine transporter (DAT) availability in each striatal sub-region and applied the Scheltens scale to assess the severity of periventricular and deep WMHs. The relationships between WMHs, DAT availability, and cognition in PD were assessed using multivariate linear regression and mediation analyses while adjusting for age at parkinsonian symptom onset, sex, disease duration, and vascular risk factors.

RESULTS

The severities of periventricular and frontal WMHs were associated with striatal DAT availability. Periventricular WMHs affected the level of cognitive performance in all cognitive domains, while frontal WMHs affected the attention/working memory and frontal/executive function domains. The effects of WMHs on attention/working memory and frontal/executive dysfunction were mostly direct with minimal mediating effects through striatal DAT availability. Meanwhile, striatal DAT availability fully mediated the association between WMHs and cognitive impairment in the visuospatial and memory function domains.

CONCLUSION

This study demonstrated the different effects of WMHs on cognitive impairment depending on the cognitive domains in PD. These findings suggest a close link between comorbid WMHs, striatal dopamine depletion, and cognition in patients with PD.

Для цитирования: Jeong Seong Ho, Lee Hye Sun, Jung Jin Ho, Baik Kyoungwon, Sohn Young H, Chung Seok Jong, Lee Phil Hyu. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.. Parkinsonism & related disorders. 2022. DOI: 10.1016/j.parkreldis.2022.02.020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.